Showing 121–143 of 143 results

LuciStir 250 mg Capsule

Molecule : StiripentolManufacturer : Lucius Pharma

LuciSuni 12.5 mg Capsule

Molecule : SunitinibManufacturer : Lucius Pharma

LuciSuni 25 mg Capsule

Molecule : SunitinibManufacturer : Lucius Pharma

LuciSuni 50 mg Capsule

Molecule : SunitinibManufacturer : Lucius Pharma

LuciTaze 200 mg Tablet

Molecule : TazemetostatManufacturer : Lucius Pharma

LuciTeno 25 mg Tablet

Molecule : Tenofovir AlafenamideManufacturer : Lucius Pharma

LuciTepo 225 mg Tablet

Molecule : TepotinibManufacturer : Lucius Pharma

LuciTivo 0.89 mg Capsule

Molecule : TivozanibManufacturer : Lucius Pharma

LuciTivo 1.34 mg Capsule

Molecule : TivozanibManufacturer : Lucius Pharma

LuciTofa 5 mg Tablet

Molecule : TofacitinibManufacturer : Lucius Pharma

LuciTram 2 mg Tablet

Molecule : TrametinibManufacturer : Lucius Pharma

LuciTrelag 100 mg Tablet

Molecule : TrelagliptinManufacturer : Lucius Pharma

LuciTuca 150 mg Tablet

Molecule : TucatinibManufacturer : Lucius Pharma
LuciTuca 150 mg Tablet is an advanced cancer therapy containing Tucatinib, a highly selective oral small-molecule inhibitor targeting the HER2

LuciUpa 15 mg Tablet

Molecule : UpadacitinibManufacturer : Lucius Pharma

LuciValgan 450 mg Tablet

Molecule : ValganciclovirManufacturer : Lucius Pharma

LuciVemu 240 mg Tablet

Molecule : VemurafenibManufacturer : Lucius Pharma

LuciVenet 100 mg Tablet

Molecule : VenetoclaxManufacturer : Lucius Pharma

LuciVibe 75 mg Tablet

Molecule : VibegronManufacturer : Lucius Pharma

LuciViga 500 mg Tablet

Molecule : VigabatrinManufacturer : Lucius Pharma

LuciVora 40 mg Tablet

Molecule : VorasidenibManufacturer : Lucius Pharma

Lucivos 250 mg Tablet

Molecule : IvosidenibManufacturer : Lucius Pharma
LuciVos 500 mg Tablet is a once-daily, oral precision oncology treatment that contains ivosidenib, a first-in-class inhibitor of isocitrate dehydrogenase-1

LuciXaz 4 mg Capsule

Molecule : IxazomibManufacturer : Lucius Pharma

LuciZonger 60 mg Tablet

Molecule : ZongertinibManufacturer : Lucius Pharma